Variant in the ATP1A3 gene: a review of current literature and the development of CAPOS syndrome in a preterm infant – a clinical case report

Abstract

The integration of modern molecular genetic methods, particularly Next-Generation Sequencing (NGS), into clinical practice has expanded diagnostic capabilities for children from the neonatal period onward. Early genetic disease detection is a promising avenue for advancing neonatology and pediatrics. It enables timely treatment selection and adjustment, prognosis determination, and genetic counseling for affected families.

Hereditary nervous system disorders often manifest in the neonatal period as convulsive syndromes mimicking perinatal complications. Their etiology is frequently diagnosed much later, delaying pathogenetic therapy initiation and contributing to early disability in affected children.

Various authors estimate the average age for diagnostics of genetically-caused nervous system developmental disorders as 3–6 years.

Pathogenic ATP1A3 mutations are the primary cause of several rare neurological disorders in infants and children with overlapping phenotypes. These include Alternating Hemiplegia of Childhood 2 (AHC2), Rapid-Onset Dystonia-Parkinsonism (DYT12 or RDP), CAPOS syndrome (Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy, and Sensorineural hearing loss), Developmental and Epileptic Encephalopathy 99 (DEE99), and Childhood-Onset Schizophrenia (COS).

The prevalence of ATP1A3-related disorders remains unclear due to rarity, diverse clinical manifestations and gradual development of characteristic symptom complexes.

Aim. This clinical observation describes a very premature infant with a variant in the ATR1A3 gene, highlighting the distinctive features and stages of the differential diagnostic search during the neonatal period. The case study focuses on the formation of geno-phenotypic correlations typical of CAPOS syndrome and the degree of their manifestation in the presented patient.

This article presents a clinical case of a severely premature infant diagnosed with an ATP1A3 gene variant. It also reviews current literature on ATP1A3 variant phenotypes, pathogenesis, clinical features, diagnostic approaches and rehabilitation potential.

Keywords: premature newborn; CAPOS syndrome; ATP1A3 gene; mutation; whole exome sequencing; congenital cataract; hearing loss

Funding. The study had no sponsorship.

Conflict of interest. Authors declare no conflict of interest.

Contribution. Idea, concept and design of the article – Nikitina I.V., Amelin I.M.; writing the text – Nikitina I.V., Dokshukina A.A., Amelin I.M., Ushakova L.V.; editing – Zubkov V.V., Lenyushkina A.A., Nikitina I.V., Ushakova L.V.

Acknowledgments. We would like to thank Maslennikov D.N., Kochetkova T.O. for their assistance in analyzing the bioinformatics data.

For citation: Nikitina I.V., Amelin I.M., Ushakova L.V., Dokshukina A.A., Lenushkina A.A., Zubkov V.V. Variant in the ATP1A3 gene: a review of current literature and the development of CAPOS syndrome in a preterm infant – a clinical case report. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2025; 13 (1): 60–8. DOI: https://doi.org/10.33029/2308-2402-2025-13-1-60-68 (in Russian)

References

1. Kotova E.G., Kobyakova O.S., Aleksandrov A.G. Morbidity of the entire population of Russia in 2021: statistical materials. TsNIIOIZ Minzdrava Rossii, 2022: 145 p. (in Russian)

2. Du X., Glass J.E., Balow S., Dyer L.M., Rathbun P.A., Guan Q., et al. Genetic testing in patients with neurodevelopmental disorders: experience of 511 patients at Cincinnati Children’s Hospital Medical Center. J Autism Dev Disord. 2022; 52 (11): 4828–42.

3. Shin S., Lee J., Kim Y.G., Ha C., Park J.H., Kim J.W., et al. Genetic diagnosis of children with neurodevelopmental disorders using whole genome sequencing. Pediatr Neurol. 2023; 149: 44–52.

4. Boulton K.A., Hodge M., Jewell A. Diagnostic delay in children with neurodevelopmental conditions attending a publicly funded developmental assessment service: findings from the Sydney Child Neurodevelopment Research Registry. BMJ Open. 2023; 13 (2): e069500.

5. de Carvalho Aguiar P., Sweadner K.J., Penniston J.T., Zaremba J., Liu L., Caton M., et al. Mutations in the Na+/K+-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron. 2004; 43 (2): 169–75.

6. Kaplan J.H. Biochemistry of Na,K-ATPase. Annu Rev Biochem. 2002; 71: 511–35.

7. Palmgren M.G., Nissen P. P-type ATPases. Annu Rev Biophys. 2011; 40: 243–66.

8. Holm T.H., Lykke-Hartmann K. Insights into the pathology of the α3 Na+/K+-ATPase ion pump in neurological disorders; lessons from animal models. Front Physiol. 2016; 7: 209.

9. Dobretsov M., Stimers J.R. Neuronal function and alpha3 isoform of the Na/K-ATPase. Front Biosci J. 2005; 10: 2373–96.

10. Kristensen A.S., Andersen J., Jorgensen T.N., Sorensen L., Eriksen J., Loland C.J., et al. SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev. 2011; 63 (3): 585–640.

11. Heinzen E.L., Swoboda K.J., Hitomi Y., Gurrieri F., Nicole S., de Vries B., et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012; 44 (9): 1030–4.

12. Bottger P., Tracz Z., Heuck A., Nissen P., Romero-Ramos M., Lykke-Hartmann K. Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain. J Comp Neurol. 2011; 519 (2): 376–404.

13. Salles P.A., Mata I.F., Brünger T., Lal D., et al. ATP1A3-related disorders: an ever-expanding clinical spectrum. Front Neurol. 2021; 12: e637890.

14. Vezyroglou A., Akilapa R., Barwick K., Koene S., Brownstein C.A., Holder-Espinasse M., et al. The phenotypic continuum of ATP1A3-related disorders. Neurology. 2022; 99 (14): e1511–26.

15. Gorokhovsky A.N. Gene ATP1A3 [Electronic resource]. In: GENOCARTA Genetic Encyclopedia. 2023. URL: https://www.genokarta.ru/gene/ATP1A3 (date of access September 19, 2024). (in Russian)

16. INTERGROWTH-21st [Electronic resource]. URL: http://intergrowth21.ndog.ox.ac.uk/en/ManualEntry/Compute (date of access July 11, 2024).

17. Bykova Y.K. Hemorrhagic lesions of the brain in premature infants: pathogenesis and ultrasound diagnosis. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2024; 12 (1): 47–57. (in Russian)

18. Kryuchko D.S. Arterial hypotension and shock in newborns (Protocol). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2016; (2): 108–22. (in Russian)

19. Burov A.A., Degtyarev D.N., Ionov O.V., Kryuchko D.S., Mitupov Z.P., Movsesyan R.R., et al. Patent ductus arteriosus in premature infants. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2016; (4): 120–8. (in Russian)

20. Dorofeeva E.I., Podurovskaya Y.L., Burov A.A., Ryumina I.I., Narogan M.V., et al. Diagnosis and conservative treatment of newborns with necrotizing enterocolitis (clinical recommendations project). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2014; (2): 84–92. (in Russian)

21. Russian Society of Neonatologists. Congenital pneumonia (clinical recommendations). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2017; (4): 133–48. (in Russian)

22. Balashova E.N., Vasil’ev E.N., Vaynshtein N.P., Degtyareva M.V., Zubkov V.V., et al. Congenital cytomegalovirus infection (clinical recommendations). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2023; 11 (4): 68–87. (in Russian)

23. Russian Society of Neonatologists. Invasive candidiasis in newborns (clinical recommendations). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2017; (4): 120–32. (in Russian)

24. Balashova E.N., Sharafutdinova D.R., Narogan M.V., Puchkova A.A., Degtyareva A.V., et al. Early anemia in premature infants (clinical recommendations). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2021; 9 (3): 47–61. (in Russian)

25. Sabouraud P., Riquet A., Spitz M.A., Deiva K., Nevsimalova S., Mignot C., et al. Relapsing encephalopathy with cerebellar ataxia caused by variants involving p.Arg756 in ATP1A3. Eur J Paediatr Neurol. 2019; 23 (3): 448–55.

26. Nicolaides P., Appleton R.E., Fryer A. Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. J Med Genet. 1996; 33 (5): 419–21.

27. Demos M.K., van Karnebeek C.D., Ross C.J., Adam S., Shen Y., Zhan S.H., et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis. 2014; 9 (1): 15.

28. Carecchio M., Zorzi G., Ragona F., Zibordi F., Nardocci N. ATP1A3-related disorders: an update. Eur J Paediatr Neurol. 2018; 22 (2): 257–63.

29. Stenshorne I., Rasmussen M., Salvanos P., Tallaksen C.M.E., Bindoff L.A., Koht J. Fever-related ataxia: a case report of CAPOS syndrome. Cerebellum Ataxias. 2019; 6 (1): 2.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Degtyarev Dmitriy Nikolaevich
Doctor of Medical Sciences, Professor, Deputy Director for Scientific Research of the V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Head of the Chair of Neonatology at the Clinical Institute of Children's Health named after N.F. Filatov, I.M. Sechenov First Moscow State Medical University, Chairman of the Ethics Committee of the Russian Society of Neonatologists, Moscow, Russian Federation

ORCID iD 0000-0001-8975-2425
geotar-digit

Journals of «GEOTAR-Media»